Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
A phase I/II study is conducted to determine the maximum-tolerated dose (MTD), dose-limiting
toxicity (DLT), and efficacy of a combination chemotherapy using docetaxel, cisplatin and
5-fluorouracil (TPF) in Pre-treated patients with metastatic esophageal cancer. The
usefulness of the this regimen is evaluated by response rate, median survival time, and
progression free survival.